Prestige Biopharma appoints Nexia Samduk as external auditor
Prestige Biopharma appointed Nexia Samduk as external auditor, replacing its prior auditor. The audit contract runs from July 1, 2026 to June 30, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.